Charles Schlesinger, DDS, will present “Enhanced Patient Care Through the Use of CBCT” at the 2016 Vatech 3D Symposium on Friday, April 15 from 3:30 to 4:45 p.m. at the Westin Long Beach in Long Beach, Calif.
Schlesinger is the chief operating officer and director of clinical affairs at OCO Biomedical. During the AGD-Pace accredited event, he will describe how CBCT can enhance treatment as well as facilitate immediate loading protocols and 3-D guided surgery.
“I am privileged to have the opportunity to lecture at this wonderful event,” Schlesinger said. “Vatech is an integral partner of OCO Biomedical, and our symbiotic relationship helps practitioners achieve the ultimate in patient satisfaction.”